3.95
price up icon0.51%   0.02
after-market アフターアワーズ: 3.71 -0.24 -6.08%
loading

Genelux Corp (GNLX) 最新ニュース

pulisher
Jan 28, 2025

Oncolytic Viruses Market Expected to rise, 2034 | Targovax, Replimune, Genelux Corporation, Candel Therapeutics, DNAtrix, SillaJen, Treovir, Lokon Pharma AB, Istari Oncology, CG Oncology, Amgen - Barchart

Jan 28, 2025
pulisher
Jan 24, 2025

Genelux (GNLX) Stock Price, News & Analysis - MarketBeat

Jan 24, 2025
pulisher
Jan 24, 2025

We Think Genelux (NASDAQ:GNLX) Needs To Drive Business Growth Carefully - Yahoo Finance

Jan 24, 2025
pulisher
Jan 23, 2025

Could Genelux's Olvi-Vec Emerge As A Powerful Tool In The Fight Against Difficult-to-treat Cancers? - RTTNews

Jan 23, 2025
pulisher
Jan 12, 2025

Geode Capital Management LLC Has $749,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Jan 12, 2025
pulisher
Dec 31, 2024

Genelux director Tyree James L sells shares worth $8,511 - Investing.com India

Dec 31, 2024
pulisher
Dec 30, 2024

Genelux director Tyree James L sells shares worth $8,511 By Investing.com - Investing.com Nigeria

Dec 30, 2024
pulisher
Dec 23, 2024

XTX Topco Ltd Invests $59,000 in Genelux Co. (NASDAQ:GNLX) - Defense World

Dec 23, 2024
pulisher
Dec 19, 2024

Genelux VP sells shares worth $14,742 By Investing.com - Investing.com Australia

Dec 19, 2024
pulisher
Dec 18, 2024

Genelux CFO Zak Lourie sells $4,921 in stock By Investing.com - Investing.com Australia

Dec 18, 2024
pulisher
Dec 18, 2024

Genelux's head of regulatory sells $5,873 in stock By Investing.com - Investing.com Australia

Dec 18, 2024
pulisher
Dec 18, 2024

Genelux CFO Zak Lourie sells $4,921 in stock - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Genelux VP sells shares worth $14,742 - Investing.com

Dec 18, 2024
pulisher
Dec 13, 2024

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - Yahoo Finance

Dec 13, 2024
pulisher
Nov 19, 2024

HC Wainwright Cuts Genelux (NASDAQ:GNLX) Price Target to $30.00 - Defense World

Nov 19, 2024
pulisher
Nov 15, 2024

Genelux shares target cut, maintains buy rating on 3Q earnings - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Genelux reports Q3 EPS (19c), consensus (19c) - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Genelux Reports $6.5M Q3 Loss, Advances Lung Cancer Trials with $35.1M Cash Runway - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

Genelux Corp. Releases New Corporate Presentation - TipRanks

Nov 08, 2024
pulisher
Nov 06, 2024

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Genelux CEO to Present at Guggenheim Healthcare Innovation Conference - StockTitan

Nov 06, 2024
pulisher
Oct 31, 2024

Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Guggenheim Begins Coverage on Genelux (NASDAQ:GNLX) - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

Guggenheim sees upside in Genelux shares, targets $8 as pivotal cancer trial progresses - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Brokerages Set Genelux Co. (NASDAQ:GNLX) PT at $22.33 - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp - Yahoo Finance

Oct 25, 2024
pulisher
Oct 23, 2024

Genelux doses first subject in Phase II trial of NSCLC treatment - Yahoo Finance

Oct 23, 2024
pulisher
Oct 22, 2024

Genelux advances NSCLC treatment with Phase 2 Olvi-Vec trial - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - Yahoo Finance

Oct 22, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Takes $56,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Oct 17, 2024
pulisher
Oct 14, 2024

Genelux Co. (NASDAQ:GNLX) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - Yahoo Finance

Oct 09, 2024
pulisher
Oct 04, 2024

Genelux announces executive departure By Investing.com - Investing.com Australia

Oct 04, 2024
pulisher
Oct 03, 2024

Genelux announces executive departure - Investing.com

Oct 03, 2024
pulisher
Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Acquires Shares of 20,162 Genelux Co. (NASDAQ:GNLX) - Defense World

Oct 01, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Acquires New Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 25, 2024
pulisher
Sep 19, 2024

Highbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Short Interest in Genelux Co. (NASDAQ:GNLX) Decreases By 7.3% - MarketBeat

Sep 18, 2024
pulisher
Sep 14, 2024

Genelux corp insider sells over $170k in company stock - Investing.com India

Sep 14, 2024
pulisher
Sep 12, 2024

Genelux director Tyree James L sells shares worth over $4,400 - Investing.com India

Sep 12, 2024
pulisher
Sep 11, 2024

Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $63,134.10 in Stock - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Genelux corp insider sells over $196k in company stock - Investing.com

Sep 11, 2024
pulisher
Sep 11, 2024

ROTH MKM analysts initates a Buy rating for Genelux Corp (GNLX) - Knox Daily

Sep 11, 2024
pulisher
Sep 07, 2024

Genelux Corp insider sells $89.6k in company stock By Investing.com - Investing.com Australia

Sep 07, 2024
pulisher
Sep 06, 2024

Genelux Corp insider sells $89.6k in company stock - Investing.com India

Sep 06, 2024
pulisher
Sep 06, 2024

Insider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 42,818 Shares of Stock - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp [NASDAQ: GNLX] Sees Increase in Stock Value - Knox Daily

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp (GNLX) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 06, 2024
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):